GLSI
Greenwich LifeSciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$17.41
−8.37%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.30
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.27
- EPS estimate
- -$0.33
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -6.3%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.33 | -$0.27 | Beat 18.18% | — |
| Jun 3, 2026 | -$0.33 | -$0.39 | Miss -18.18% | — |
| Nov 14, 2025 | -$0.30 | -$0.30 | In line | — |
| Aug 14, 2025 | -$0.24 | -$0.30 | Miss -25.00% | — |
| May 20, 2025 | -$0.24 | -$0.25 | Miss -4.17% | — |
| Nov 14, 2024 | -$0.21 | -$0.20 | Beat 4.76% | — |
| Aug 14, 2024 | -$0.20 | -$0.20 | In line | — |
| May 20, 2024 | -$0.20 | -$0.19 | Beat 5.00% | — |
| Oct 19, 2023 | -$0.22 | -$0.19 | Beat 13.64% | — |
| Aug 21, 2023 | -$0.23 | -$0.13 | Beat 43.48% | — |
| May 22, 2023 | -$0.23 | -$0.17 | Beat 26.09% | — |
| Mar 31, 2023 | -$0.18 | -$0.22 | Miss -22.22% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026